AWA
CLB icon

Argos Wealth Advisors’s Core Laboratories CLB Stock Holding History

Argos Wealth Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,119
Closed -$271K – 226
2026
Q1 		$271K Hold
16,119
– – 0.08% 142
2025
Q4 		$258K Buy
+16,119
New +$240K 0.07% 155

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Argos Wealth Advisors's CLB Position: Q2 2026 in Review

Argos Wealth Advisors sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 16,119 shares — an estimated $271K sold.

Argos Wealth Advisors first reported a position in CLB in Q4 2025 and held it in 2 quarters. The position peaked at $271K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Argos Wealth Advisors reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Argos Wealth Advisors sold 16,119 Core Laboratories shares in Q2 2026, an estimated $271K.
  • Argos Wealth Advisors first reported a position in Core Laboratories in Q4 2025 and held it in 2 quarters.
  • Argos Wealth Advisors's Core Laboratories position peaked at $271K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Argos Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.